Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

THE TV – “Feel tired? Out of energy? Then you need Oxyoxt.” “I used to have broken bones, cancer of the thumbs and nightmares ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Aims to revolutionize pharmaceutical manufacturing with focus on advanced aseptic processing technology.

The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgery or injury, the ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Long Island Congressman Nick Lalota is part of a group planning to hold up the nation's tax bill if the cap is not nixed. CBS ...